Both in Pharmaceuticals
Cronos Group Inc. Common Share vs Innoviva
Over the past year CRON returned +51.8% and INVA returned +5.5%; their daily moves had a correlation of 0.06.
CRON +51.8% INVA +5.5%Growth of $1, one year, split-adjusted
| Metric | CRON | INVA |
|---|---|---|
| Price | $3.72 | $19.24 |
| Market cap | $1.37B | $1.39B |
| Today | +5.98% | −9.50% |
| 1 month | +14.8% | −8.6% |
| 6 months | +44.7% | −15.6% |
| Year to date | +41.4% | −3.8% |
| 1 year | +51.8% | +6.0% |
| Revenue growth (YoY) | +59.5% | +19.3% |
| Gross margin | 65.8% | 81.3% |
| Net margin | 45.4% | −69.8% |
| P/E (TTM) | 19.6× | 3.9× |
| Price / sales | 5.3× | 3.2× |
| Net cash | $797.0M | $319.0M |
| Dividend yield | — | — |
| Volatility (60d) | 31.4% | 29.3% |
| Short % of float | 2.1% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).